• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Pharmacy Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 9 (2025)
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Volume Volume 5 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Khedr, R., Ahmed, A., Kamel, R., Rafaat, E. (2021). Antioxidant Effects of Sitagliptin in a Rat Model of Intestinal Ischemia/Reperfusion Injury. Journal of Advanced Pharmacy Research, 5(1), 234-240. doi: 10.21608/aprh.2020.49560.1119
Rehab Khedr; Amany Ahmed; Rehab Kamel; Eman Rafaat. "Antioxidant Effects of Sitagliptin in a Rat Model of Intestinal Ischemia/Reperfusion Injury". Journal of Advanced Pharmacy Research, 5, 1, 2021, 234-240. doi: 10.21608/aprh.2020.49560.1119
Khedr, R., Ahmed, A., Kamel, R., Rafaat, E. (2021). 'Antioxidant Effects of Sitagliptin in a Rat Model of Intestinal Ischemia/Reperfusion Injury', Journal of Advanced Pharmacy Research, 5(1), pp. 234-240. doi: 10.21608/aprh.2020.49560.1119
Khedr, R., Ahmed, A., Kamel, R., Rafaat, E. Antioxidant Effects of Sitagliptin in a Rat Model of Intestinal Ischemia/Reperfusion Injury. Journal of Advanced Pharmacy Research, 2021; 5(1): 234-240. doi: 10.21608/aprh.2020.49560.1119

Antioxidant Effects of Sitagliptin in a Rat Model of Intestinal Ischemia/Reperfusion Injury

Article 6, Volume 5, Issue 1, January 2021, Page 234-240  XML PDF (371.19 K)
Document Type: Research Article
DOI: 10.21608/aprh.2020.49560.1119
View on SCiNiTO View on SCiNiTO
Authors
Rehab Khedr email ; Amany Ahmedorcid ; Rehab Kamel; Eman Rafaat
Pharmacology and Toxicology Department, Faculty of Pharmacy, Helwan University, Helwan, Cairo, Egypt
Abstract
Objectives: This study aimed to assess the possible antioxidant role of sitagliptin on intestinal ischemia/reperfusion (II/R)-mediated tissue injury. Methods: Forty-five male Sprague-Dawley rats were randomly assigned into three groups: Sham group (operation without clamping), II/R group (operation with clamping) and Sitagliptin pretreated group (300 mg/kg/day; orally by gavage) for 2 weeks before II/R insult. II/R was performed by clamping the superior mesenteric artery for 30 min, followed by 60 min reperfusion after removal of clamping. At the end of the experimental period, all rats were sacrificed for biochemical assessment of oxidative stress parameters. Results: Pretreatment with sitagliptin remarkably alleviated the oxidative stress response induced by I/R in the jejunum manifested by a marked reduction of the pro-oxidant NOX-2 enzyme level, the lipid peroxidation marker, MDA content and the nitrosative stress indicator, NO content as well as replenishing the key cellular enzymatic antioxidant, SOD activity. Conclusion: Sitagliptin has a potential antioxidant effect against II/R injury in rats and thus we assume sitagliptin may be a beneficial prophylactic drug in patients at risk of intestinal I/R injury.
Keywords
Sitagliptin; Ischemia; Reperfusion injury; Intestine; Oxidative stress
Main Subjects
Section D: Clinical Pharmacy & Pharmacology
Statistics
Article View: 492
PDF Download: 552
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.